givinostat hydrochloride,
ITF 2357,
ITF2357,
Givinostat hydrochloride,
199657-29-9,
Givinostat HCl,
Givinostat (hydrochloride),
UNII-Z02132R2QQ,
Z02132R2QQ,
ITF2357,
ITF 2357,
Histone deacetylase inhibitor,
Carbamic acid, N-(4-((hydroxyamino)carbonyl)phenyl)-, (6-((diethylamino)methyl)-2-naphthalenyl)methyl ester, hydrochloride (1:1),
Carbamic acid, N-[4-[(hydroxyamino)carbonyl]phenyl]-, [6-[(diethylamino)methyl]-2-naphthalenyl]methyl ester, hydrochloride (1:1),
C24H27N3O4.ClH,
2652AH,
HY-14842A,
MFCD28502062,
AKOS030526700,
CS-4728,
SB16937,
AS-52365,
KS-00000644,
EN300-257964,
[6-[(Diethylamino)methyl]-2-naphthalenyl]methyl-N-[4-[(hydroxyamino)carbonyl]phenyl]carbamate hydrochloride,
Givinostat,
HDAC Inhibitors,
Inhibitors, HDAC,
Histone Deacetylase Inhibitors,
Deacetylase Inhibitor, Histone,
Inhibitor, Histone Deacetylase,
Deacetylase Inhibitors, Histone,
Inhibitors, Histone Deacetylase,
ITF-2357,
CID10095659,
CID 10095659,
D056572,
732302-99-7,